help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janicki, S. M.
Right arrow Articles by Monteiro, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janicki, S. M.
Right arrow Articles by Monteiro, M. J.
(American Journal of Pathology. 1999;155:135-144.)
© 1999 American Society for Investigative Pathology

Regular Articles

Presenilin Overexpression Arrests Cells in the G1 Phase of the Cell Cycle

Arrest Potentiated by the Alzheimer's Disease PS2(N141I)Mutant

Susan M. Janicki and Mervyn J. Monteiro

From the Medical Biotechnology Center and Department of Neurology and Division of Human Genetics, University of Maryland, Baltimore, Maryland

To investigate the mechanism by which presenilin (PS) overexpression induces apoptosis, we studied the effects of these proteins on cell cycle progression. Transiently transfected HeLa cells were bromodeoxyuridine (BrdU) labeled to visualize DNA synthesis by immunofluorescence and stained with propidium iodide to measure DNA content by fluorescence-activated cell sorting (FACS). BrdU labeling was decreased in cells expressing presenilin-1 (PS1), presenilin-2 (PS2), an Alzheimer's disease-associated missense mutation PS2(N141I), and the carboxyl-terminally deleted PS2 construct PS2(166aa), compared with mock and neurofilament-light (NF-L) transfected cells. Analysis of BrdU incorporation in mitotically synchronized HeLa cells suggested that cells were arresting in the G1 phase of the cell cycle, and this was confirmed by FACS analysis. Interestingly, cell cycle progression was more inhibited by the expression of PS2(N141I) compared with wild-type PS2. In addition, ATM, the gene product mutated in ataxia-telangiectasia, does not appear to be a downstream effector of PS-induced cell cycle arrest as transfection of PS constructs into an ataxia-telangiectasia cell line also resulted in cell cycle inhibition. Quantitative immunoblotting of whole-cell lysates from PS-transfected cells did not reveal increases or decreases in the steady-state levels of p21, p27, p53, pRb, or c-myc, suggesting that the presenilins mediate cell cycle arrest by mechanisms other than simple changes in the steady-state levels of these cell-cycle-related proteins.




This article has been cited by other articles:


Home page
 J. Cell Biol.Home page
A. L. Mah, G. Perry, M. A. Smith, and M. J. Monteiro
Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation
J. Cell Biol., November 13, 2000; 151(4): 847 - 862.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S.-J. JEONG, H.-S. KIM, K.-A CHANG, D.-H. GEUM, C. H. PARK, J.-H. SEO, J.-C. RAH, J. H. LEE, S. H. CHOI, S. G. LEE, et al.
Subcellular localization of presenilins during mouse preimplantation development
FASEB J, November 1, 2000; 14(14): 2171 - 2176.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.